DEUTERATED INFIGRATINIB COMPOUNDS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 27, 2025
app pub date -
Mar 8, 2024
filing date -
Mar 8, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Provided herein are compounds, or salts (e.g., pharmaceutically acceptable salts), esters, tautomers, prodrugs, zwitterionic forms, or stereoisomers thereof, which compounds comprise one or more deuterium atoms, as well as pharmaceutically compositions comprising the same. Also provided herein are methods of using the same in the treatment of various diseases, disorders, and conditions including cancers and skeletal dysplasias.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully